Retinoid-containing medicinal products and Neuropsychiatric disorders: A descriptive analysis of EudraVigilance data

20/01/2021
02/04/2024
EU PAS number:
EUPAS36901
Study
Finalised
Documents
Study protocol
Initial protocol
English (109.66 KB - PDF) View document
Study results
Study results
English (592.05 KB - PDF) View document
Study report
Other information